Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 9, 2007 Rich Duprey	BioLase's Dull Quarter The dental laser maker makes good on its promise of a disappointing quarter, but the future may be bright for investors.
The Motley Fool March 15, 2007 Rich Duprey	Biolase's Brighter Sales Figures With a firm financial footing in place, even after its shares have risen 50% in the past three months, Biolase could be an addition to your portfolio worth smiling about.
The Motley Fool November 8, 2006 Rich Duprey	BioLase's Reason to Smile Dental laser maker narrows loss and inks distribution deal to boost sales. The stock is a little rich at its current prices, though. Investors, take note.
The Motley Fool January 10, 2006 Rich Duprey	Biolase Brightens Outlook The aesthetic laser company expects to be cash flow-neutral on flat revenues. Investors cheer.
The Motley Fool July 20, 2004 Rich Duprey	Lasers Lose Focus Dental-equipment manufacturer Biolase reports flat sales.
The Motley Fool April 3, 2007 Rich Duprey	Palomar Medical Burns Another Rival The aesthetic laser maker zaps a privately held firm for patent infringement. But one company not buckling under to Palomar's aggressive tactics is Candela. Investors, take note.
The Motley Fool April 30, 2007 Rich Duprey	Foolish Forecast: Cutera Zaps Quarter Investors, don't expect the aesthetic laser maker to burn up the growth charts when it reports first-quarter results.
The Motley Fool November 2, 2005 Rich Duprey	Can Candela Regain Focus? Aesthetic laser maker reports strong gains, but can it do so consistently? It has new products, new distributors, and new markets to expand into, along with a shareholder-friendly stock buyback program.
The Motley Fool April 17, 2007 Rich Duprey	Foolish Forecast: A Bet Candela Can't Afford to Lose The aesthetic laser maker is set to report third-quarter 2007 financial results. Investors, here is what you can expect to see.
The Motley Fool November 8, 2006 Rich Duprey	BioLase Brightens Smiles: Fool by Numbers The dental laser maker released fiscal third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool May 5, 2005 Rich Duprey	Candela Brightens on Sales Growth The laser manufacturer reports record revenues and growing profits. Though not a sell, this stock isn't as hot as expected.
BusinessWeek December 8, 2003 Gene G. Marcial	More Dentists Are Drilling With Biolase Biolase makes laser dental drills quieter and less painful. The stock was knocked down because of an accounting restatement, but some pros think it is a good buy.
The Motley Fool September 12, 2006 Rich Duprey	A Fuzzy Forecast for Candela Based on company-specific trends, the balance of 2006 will be a bust for the aesthetic laser maker. Investors, take note.
BusinessWeek November 29, 2004 Gene G. Marcial	Will More Dentists Ask For Biolase Drills? A management shakeup and a new product at Biolase Technology have rekindled interest in the stock, which has been in a deep funk.
The Motley Fool March 15, 2007 Rich Duprey	Candela Eases the Pain The aesthetic laser maker acquires an innovative technology that minimizes pain. Investors, it's essentially an investment in the future, but one that still entails some risk.
The Motley Fool April 24, 2008 Rich Duprey	Candela Fizzles Aesthetic laser maker Candela reports slightly higher revenue but wider-than-anticipated losses.
The Motley Fool April 25, 2007 Rich Duprey	Candela's Amazing Shrinking Quarter The aesthetic laser maker reports its second consecutive quarter of declining sales. Investors, take note.
The Motley Fool April 29, 2005 Rich Duprey	Will Candela Burn Investors Again? Laser maker set to report earnings next week, but spotty record casts doubt on outcome.
The Motley Fool August 18, 2006 Rich Duprey	Candela Singed by Patent Lawsuit The cosmetic laser maker, hit by rival's claim of infringement, fires back with a counterclaim. Investors, with Candela releasing its earnings report next week, this is sure to be a white hot topic on the conference call. Investors, take note.
The Motley Fool January 17, 2007 Rich Duprey	Foolish Forecast: Dim Hope for Candela The aesthetic-laser maker will report second-quarter 2007 financial results shortly. Investors, here what to expect.
The Motley Fool July 30, 2004 J. Graham	Biolase by the Numbers The dental laser company is trying to shore up investor confidence by declaring a dividend and shaking up management, but their poor numbers, among other problems, keep it from being a good buy for now.
The Motley Fool April 10, 2007 Rich Duprey	The Beauty of Lasers With aesthetic laser treatments booming, which company looks the best? Candela... Cutera... Palomar Medical Technologies... Cynosure... Syneron...
The Motley Fool August 22, 2006 Rich Duprey	Candela Goes Dark Atop recent legal woes, the laser maker reports gloomy quarterly earnings. Investors, take note.
The Motley Fool April 22, 2008 Rich Duprey	Foolish Forecast: No Sizzle at Candela In advance of earnings, analysts expect sales from aesthetic laser maker Candela to be essentially flat.
The Motley Fool March 24, 2006 Rich Duprey	Honing In on Laserscope The medical-use laser manufacturer may get a boost from a laser deal with China. Investors, one deal does not a quarter make, but it could be signal that the tide is turning for this leading medical device laser manufacturer.
The Motley Fool November 5, 2004 Rich Duprey	Profit From Management Integrity Laser manufacturer Candela's management avoids taking the easy way out to explain shortfalls. It's a sign of management integrity that will lead to future profits.
The Motley Fool February 13, 2006 Stephen D. Simpson	Will Syneron Defy History? Publicly traded laser companies have a legacy of failure; will Syneron manage to turn that tide?
The Motley Fool October 26, 2006 Rich Duprey	Candela's October Surprise The aesthetic laser maker trounces analyst projections, though all may not be what it seems. Investors, take note.
The Motley Fool January 24, 2007 Rich Duprey	Candela's Number Is Up The aesthetic laser maker reports dismal results that fall short of its own fuzzy math expectations.
The Motley Fool September 10, 2007 Rich Duprey	A Strategic Alternative for Candela In an SEC filing, hedge fund Third Point LLC reports its discussions of "strategic alternatives" at laser maker Candela. Some say a sale was discussed. Investors should take notice.
The Motley Fool June 22, 2004 Dave Marino-Nachison	Schein Over Europe On Friday, dental and medical products distributor Henry Schein completed the purchase of a set of European operations with roughly $340 million in sales for the fiscal year ended Sept. 30
The Motley Fool October 7, 2004 Seth Jayson	Painless? My Assets Another warning from dental tech firm Biolase Technology sends the stock down.
The Motley Fool March 2, 2004 Seth Jayson	The Shine at Schein The medical supplier continues its solid growth.
The Motley Fool November 23, 2005 Stephen D. Simpson	Is It Safe for Patterson? A tougher market and high valuation don't make this dental, veterinary, and rehab supplier an especially compelling investment idea.
The Motley Fool March 2, 2005 Dave Marino-Nachison	Henry Schein Shines On Trouble with partner Chiron's full vaccines hasn't stopped Henry Schein's share rise.
The Motley Fool December 13, 2005 Stephen D. Simpson	A Toothache at Sybron Dental Investors bail out in the wake of the company's fourth-quarter announcement.
The Motley Fool September 23, 2004 Rich Duprey	Dentsply Is More Than a Mouthful Dental supply company increases cash dividend by 14% amid torrid growth.
The Motley Fool May 25, 2006 Stephen D. Simpson	Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business.
BusinessWeek April 4, 2005 Gene G. Marcial	Schein Gets Over The Flu Henry Schein, the top producer of flu vaccines in the U.S., reported notable fourth-quarter earnings despite the mandated stoppage of vaccine production last year.
The Motley Fool January 3, 2007 Matthew Crews	Henry Schein Herds Immunity The vaccine distributor hopes a strong 2007 will help revive its earnings. Value investors should put Henry Schein on their watch lists until it presents a greater margin of safety.
Military & Aerospace Electronics December 2007 John Keller	Fiber Laser Sales to Grow 26 Percent Annually Through 2011 Many key questions remain, such as how fast and how much market share can kilowatt fiber lasers gain from carbon dioxide lasers in sheet metal cutting? And, how much vertical integration is necessary to succeed in the fiber laser market?